Clinical Trials Browser

Phase 3 × INDUSTRY × 3-Iodobenzylguanidine × Clear all

NCT00126412 2019-05-31

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Phase 3 Completed

Disease, Neuroblastoma, Pheochromocytoma